AMGT-0230

N/A

Report date: 2025/06/06 16:48:36
NME

Base Information

Drug NameAMGT-0230
Drug Alias NameAMGT-0230
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D2 receptor agonistsDopamine D3 receptor agonists
TargetsDopamine D2 receptorDopamine D3 receptor
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAmalgent Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesAmalgent Therapeutics LLC
Inactive CompaniesN/A
Active IndicationsPain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A